Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Obstructive Lung Diseases

  Free Subscription


06.05.2019

3 Allergy
2 Am J Respir Cell Mol Biol
1 Am J Respir Crit Care Med
2 Ann Allergy Asthma Immunol
2 Chest
2 Clin Exp Allergy
4 Eur Respir J
3 J Allergy Clin Immunol
3 J Asthma
4 Lancet Respir Med
1 N Engl J Med
1 Proc Natl Acad Sci U S A
9 Respir Med
1 Respir Res


  Retrieve available abstracts of this week’s articles:
HTML format
Text format
 
 
Single Articles


    Allergy

  1. CHAPMAN KR, Albers FC, Chipps B, Munoz X, et al
    The clinical benefit of mepolizumab replacing omalizumab in uncontrolled severe eosinophilic asthma.
    Allergy. 2019 May 2. doi: 10.1111/all.13850.
    PubMed     Text format     Abstract available

  2. WALTER J, O'Mahony L
    The Importance of Social Networks - An Ecological and Evolutionary Framework to Explain the Role of Microbes in the Aetiology of Allergy and Asthma.
    Allergy. 2019 Apr 29. doi: 10.1111/all.13845.
    PubMed     Text format     Abstract available

  3. VENTER C, Meyer RW, Nwaru BI, Roduit C, et al
    EAACI position paper: Influence of dietary fatty acids on asthma, food allergy, and atopic dermatitis.
    Allergy. 2019 Apr 29. doi: 10.1111/all.13764.
    PubMed     Text format     Abstract available


    Am J Respir Cell Mol Biol

  4. MADISON MC, Kheradmand F
    Taming Peptides with Peptides: Neutralizing PGPs with RTRs to Treat Cigarette Smoke-Induced Emphysema.
    Am J Respir Cell Mol Biol. 2019 May 2. doi: 10.1165/rcmb.2019-0145.
    PubMed     Text format    

  5. MOVASSAGH H, Ojo OO, Mohammed A, Shan L, et al
    Genetic Deletion of Semaphorin 3E Aggravates Airway Contraction in a Mouse Model of Allergic Asthma.
    Am J Respir Cell Mol Biol. 2019;60:601-603.
    PubMed     Text format    


    Am J Respir Crit Care Med

  6. KOJONAZAROV B, Hadzic S, Ghofrani HA, Grimminger F, et al
    Severe Emphysema in the SU5416/Hypoxia Rat Model of Pulmonary Hypertension.
    Am J Respir Crit Care Med. 2019 Apr 29. doi: 10.1164/rccm.201902-0390.
    PubMed     Text format    


    Ann Allergy Asthma Immunol

  7. NAKONECHNA A, Matthews D, Sargur R
    Occupational asthma, rhinitis, contact dermatitis and severe milk allergy caused by primary occupational exposure to casein.
    Ann Allergy Asthma Immunol. 2019 Apr 26. pii: S1081-1206(19)30320.
    PubMed     Text format    

  8. BATEMAN ED, Busse W, Pedersen SE, Bousquet J, et al
    GINA 2016-derived asthma control with fluticasone propionate/salmeterol: a Gaining Optimal Asthma controL (GOAL) study reanalysis.
    Ann Allergy Asthma Immunol. 2019 Apr 24. pii: S1081-1206(19)30317.
    PubMed     Text format    


    Chest

  9. HUNASIKATTI M
    Is Screening for Pulmonary Embolism in Patients With COPD Necessary?
    Chest. 2017;152:220-221.
    PubMed     Text format    

  10. RA SW, Sin DD
    Should We Screen for Pulmonary Embolism in Severe COPD Exacerbations? Not Just Yet, Primum Non Nocere.
    Chest. 2017;151:523-524.
    PubMed     Text format    


    Clin Exp Allergy

  11. ROBERTS G
    The end of as required inhaled short-acting bronchodilator for asthma?
    Clin Exp Allergy. 2019;49:560-561.
    PubMed     Text format    

  12. KANSEN HM, Le TM, Meijer Y, Uiterwaal CSPM, et al
    Perceived triggers of asthma impair quality of life in children with asthma.
    Clin Exp Allergy. 2019 Apr 30. doi: 10.1111/cea.13407.
    PubMed     Text format     Abstract available


    Eur Respir J

  13. TOMMOLA M, Ilmarinen P, Tuomisto LE, Lehtimaki L, et al
    Cumulative effect of smoking on disease burden and multimorbidity in adult-onset asthma.
    Eur Respir J. 2019 May 2. pii: 13993003.01580-2018.
    PubMed     Text format    

  14. CHOI H, Yang B, Nam H, Kyoung DS, et al
    Population-based prevalence of bronchiectasis and associated comorbidities in South Korea.
    Eur Respir J. 2019 May 2. pii: 13993003.00194-2019.
    PubMed     Text format    

  15. HOLLEY S, Knibb R, Latter S, Liossi C, et al
    Development and validation of the Adolescent Asthma Self-Efficacy Questionnaire (AASEQ).
    Eur Respir J. 2019 May 2. pii: 13993003.01375-2018.
    PubMed     Text format     Abstract available

  16. O'BYRNE P, Fabbri LM, Pavord ID, Papi A, et al
    Asthma progression and mortality: The role of inhaled corticosteroids.
    Eur Respir J. 2019 May 2. pii: 13993003.00491-2019.
    PubMed     Text format     Abstract available


    J Allergy Clin Immunol

  17. WHITE SR, Laxman B, Naureckas ET, Hogarth DK, et al
    Evidence for an IL-6 high asthma phenotype in asthma patients of African ancestry.
    J Allergy Clin Immunol. 2019 Apr 25. pii: S0091-6749(19)30540.
    PubMed     Text format     Abstract available

  18. KELLY KJ, Poole JA
    Pollutants in the workplace: Impact on occupational asthma.
    J Allergy Clin Immunol. 2019 Apr 25. pii: S0091-6749(19)30546.
    PubMed     Text format    

  19. STEVENS EL, Rosser F, Forno E, Peden D, et al
    Can the effects of outdoor air pollution on asthma be mitigated?
    J Allergy Clin Immunol. 2019 Apr 25. pii: S0091-6749(19)30544.
    PubMed     Text format    


    J Asthma

  20. SOCHET AA, Son S, Ryan KS, Roddy M, et al
    Stress Ulcer Prophylaxis in Children with Status Asthmaticus Receiving Systemic Corticosteroids: A Descriptive Study Assessing Frequency of Clinically Important Bleeding.
    J Asthma. 2019 May 2:1-11. doi: 10.1080/02770903.2019.1614617.
    PubMed     Text format     Abstract available

  21. PAPPALARDO AA, Glassgow EA, Kumar HV, Martin MA, et al
    CHECK: A multi-level program to improve outcomes for urban children and youth with asthma.
    J Asthma. 2019 May 2:1-4. doi: 10.1080/02770903.2019.1614616.
    PubMed     Text format    

  22. JI KIM E, Simonson J, Jacome S, Conigliaro J, et al
    Disparities in complementary alternative medicine use and asthma exacerbation in the United States.
    J Asthma. 2019 May 2:1-16. doi: 10.1080/02770903.2019.1614615.
    PubMed     Text format     Abstract available


    Lancet Respir Med

  23. THE LANCET RESPIRATORY MEDICIN
    Asthma: looking beyond the headlines.
    Lancet Respir Med. 2019;7:365.
    PubMed     Text format    

  24. BELGRAVE DCM, Granell R, Turner SW, Curtin JA, et al
    Lung function trajectories from pre-school age to adulthood and their associations with early life factors: a retrospective analysis of three population-based birth cohort studies.
    Lancet Respir Med. 2018 Apr 5. pii: S2213-2600(18)30099.
    PubMed     Text format     Abstract available

  25. PIVIDORI M, Schoettler N, Nicolae DL, Ober C, et al
    Shared and distinct genetic risk factors for childhood-onset and adult-onset asthma: genome-wide and transcriptome-wide studies.
    Lancet Respir Med. 2019 Apr 26. pii: S2213-2600(19)30055.
    PubMed     Text format     Abstract available

  26. SIROUX V, Bouzigon E
    Asthma heterogeneity: the increasing genetic evidence.
    Lancet Respir Med. 2019 Apr 26. pii: S2213-2600(19)30047.
    PubMed     Text format    


    N Engl J Med


  27. Tezepelumab in Adults with Uncontrolled Asthma.
    N Engl J Med. 2019 Apr 18. doi: 10.1056/NEJMx180026.
    PubMed     Text format    


    Proc Natl Acad Sci U S A

  28. RYCHLIK KA, Secrest JR, Lau C, Pulczinski J, et al
    In utero ultrafine particulate matter exposure causes offspring pulmonary immunosuppression.
    Proc Natl Acad Sci U S A. 2019;116:3443-3448.
    PubMed     Text format     Abstract available


    Respir Med

  29. PEREZ DE LLANO L, Martinez-Moragon E, Plaza Moral V, Trisan Alonso A, et al
    Unmet therapeutic goals and potential treatable traits in a population of patients with severe uncontrolled asthma in Spain. ENEAS study.
    Respir Med. 2019;151:49-54.
    PubMed     Text format    

  30. MOON SM, Jhun BW, Baek SY, Kim S, et al
    Long-term natural history of non-cavitary nodular bronchiectatic nontuberculous mycobacterial pulmonary disease.
    Respir Med. 2019;151:1-7.
    PubMed     Text format     Abstract available

  31. DOMVRI K, Porpodis K, Tzimagiorgis G, Chatzopoulou F, et al
    Th2/Th17 cytokine profile in phenotyped Greek asthmatics and relationship to biomarkers of inflammation.
    Respir Med. 2019;151:102-110.
    PubMed     Text format     Abstract available

  32. LICARI A, Brambilla I, Sacchi L, Marseglia G, et al
    Periostin, type 2 biomarker, is not associated with asthma control grade in asthmatic allergic children.
    Respir Med. 2019;151:118-120.
    PubMed     Text format     Abstract available

  33. DIEL R, Ewig S, Blaas S, Jacob C, et al
    Incidence of patients with non-cystic fibrosis bronchiectasis in Germany - A healthcare insurance claims data analysis.
    Respir Med. 2019;151:121-127.
    PubMed     Text format     Abstract available

  34. YANCEY SW, Bradford ES, Keene ON
    Disease burden and efficacy of mepolizumab in patients with severe asthma and blood eosinophil counts of >/=150-300cells/muL.
    Respir Med. 2019;151:139-141.
    PubMed     Text format     Abstract available

  35. BAI C, Jiang D, Wang L, Xue F, et al
    A high blood eosinophil count may be a risk factor for incident asthma in population at risk.
    Respir Med. 2019;151:59-65.
    PubMed     Text format     Abstract available

  36. CAZZOLA M, Rogliani P, Calzetta L, Matera MG, et al
    Bronchodilators in subjects with asthma-related comorbidities.
    Respir Med. 2019;151:43-48.
    PubMed     Text format     Abstract available

  37. KERWIN EM, Hickey L, Small CJ
    Relationship between handheld and clinic-based spirometry measurements in asthma patients receiving beclomethasone.
    Respir Med. 2019;151:35-42.
    PubMed     Text format     Abstract available


    Respir Res

  38. KANG HR, Hong SH, Ha SY, Kim TB, et al
    Differences in the risk of mood disorders in patients with asthma-COPD overlap and in patients with COPD alone: a nationwide population-based retrospective cohort study in Korea.
    Respir Res. 2019;20:80.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Obstructive Lung Diseases is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: